DocSym
β
Searchsearch
Search
(C93.9) Monocytic leukaemia, unspecified
More details coming soon
102 039 in individuals diagnosis monocytic leukaemia, unspecified confirmed
27 855 deaths with diagnosis monocytic leukaemia, unspecified
27% mortality rate associated with the disease monocytic leukaemia, unspecified
Diagnosis monocytic leukaemia, unspecified is diagnosed Men are 24.17% more likely than Women
63 352
Men receive the diagnosis monocytic leukaemia, unspecified
15 277 (24.1 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
38 687
Women receive the diagnosis monocytic leukaemia, unspecified
12 578 (32.5 %)Died from this diagnosis.
Risk Group for the Disease monocytic leukaemia, unspecified - Men aged 65-69 and Women aged 55-59
In Men diagnosis is most often set at age 0-9, 15-94
Less common in men the disease occurs at Age 0-1, 10-14, 95+Less common in women the disease occurs at Age 0-19, 25-34, 95+
In Women diagnosis is most often set at age 20-24, 35-94
Disease Features monocytic leukaemia, unspecified
Absence or low individual and public risk
Monocytic leukaemia, unspecified - what does this mean
Monocytic leukaemia, unspecified is a type of cancer of the blood and bone marrow in which there is an overproduction of immature monocytic cells. this is caused by a mutation in the cells of the bone marrow, causing them to divide and grow uncontrollably and crowd out normal cells. this leads to a decrease in normal blood cells, which can cause a range of symptoms, including fatigue, fever, and an increased risk of infection.
What happens during the disease - monocytic leukaemia, unspecified
Monocytic leukaemia is a type of cancer that affects the production of white blood cells in the bone marrow. it is caused by an abnormal proliferation of cells that originate in the myeloid line of the haematopoietic stem cells. this leads to an accumulation of immature monocytes in the bone marrow and peripheral blood, resulting in anemia, fatigue, and susceptibility to infection. in some cases, the accumulation of monocytes can also cause an overproduction of other myeloid cells, such as granulocytes and platelets.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete Blood Count (CBC) with differential
- Bone Marrow Biopsy
- Flow Cytometry
- Cytogenetic Analysis
- Immunophenotyping
- Molecular Testing
- Lumbar Puncture
Treatment and Medical Assistance
Main goal of the treatment: To reduce the number of abnormal white blood cells and improve the patient's quality of life.
- Chemotherapy
- Radiation therapy
- Stem cell transplant
- Targeted therapies
- Immunotherapy
- Supportive care
17 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Monocytic leukaemia, unspecified - Prevention
The best way to prevent monocytic leukaemia, unspecified is to reduce exposure to environmental toxins, maintain a healthy lifestyle, including a balanced diet and regular exercise, avoid smoking, and reduce stress. additionally, it is important to get regular medical checkups and follow up on any abnormal test results.